LivingGLP1
Study S000686

The Moody Longevity Trial: Tirzepatide to Slow Biological Aging

Registration

Registration
NCT07220473
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE2
Masking
DOUBLE
Status
RECRUITING
Enrollment
90
Start
2026-02-27
Primary completion
2027-11
Lead sponsor
The University of Texas Medical Branch, Galveston
Conditions
Aging; LONGEVITY 1
Interventions
DRUG:Zepbound
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change in DNA Methylation-Based Biological Age [Immediately before and after the study visit at Weeks 4, 12, and 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.